[ON THE EFFECT OF THE INTRAPERITONEAL ADMINISTRATION OF SUPRASTIN SOLUTION ON ASCITES TUMOR STRAINS IN MICE].
D000818:Animals; D018926:Anti-Allergic Agents; D001201:Ascites; D002277:Carcinoma; D002286:Carcinoma, Ehrlich Tumor; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D007274:Injections, Intraperitoneal; D008228:Lymphoma, Non-Hodgkin; D008660:Metabolism; D008751:Methylene Blue; D051379:Mice; D012157:Mononuclear Phagocyte System; D010600:Pharmacology; D012106:Research
D018926:Anti-Allergic Agents; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; C004664:chloropyramine; D008751:Methylene Blue
ANTIHISTAMINICS; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; LYMPHOSARCOMA; METABOLISM; METHYLENE BLUE; MICE; PHARMACOLOGY; RETICULOENDOTHELIAL SYSTEM
UBER DIE WIRKUNG INTRAPERITONEAL VERABREICHTER ISOTONISCHER SUPRASTINLOESUNG AUF DIE ASZITESTUMORENSTAEMME DER MAUS.